Cargando…
Bladder cancer stage and mortality: urban vs. rural residency
OBJECTIVE: Relative to urban populations, rural patients may have more limited access to care, which may undermine timely bladder cancer (BCa) diagnosis and even survival. METHODS: We tested the effect of residency status (rural areas [RA < 2500 inhabitants] vs. urban clusters [UC ≥ 2500 inhabita...
Autores principales: | Deuker, Marina, Stolzenbach, L. Franziska, Collà Ruvolo, Claudia, Nocera, Luigi, Tian, Zhe, Roos, Frederik C., Becker, Andreas, Kluth, Luis A., Tilki, Derya, Shariat, Shahrokh F., Saad, Fred, Chun, Felix K.H., Karakiewicz, Pierre I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810614/ https://www.ncbi.nlm.nih.gov/pubmed/33230694 http://dx.doi.org/10.1007/s10552-020-01366-1 |
Ejemplares similares
-
Differences between rural and urban prostate cancer patients
por: Stolzenbach, Lara Franziska, et al.
Publicado: (2020) -
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2021) -
Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021) -
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021) -
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)